News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Actualités Apr 17, 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News Jan 10, 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News Dec 19, 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Aktuell Oct 19, 2023 Forschende kehren Therapieresistenz bei Prostatakrebs um Forschende des Instituts für Onkologische Forschung (IOR) haben herausgefunden, wodurch Therapieresistenzen bei Prostatakrebs umgekehrt werden kö...
Actualités Aug 14, 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
News May 10, 2022 Michael J. Fox Foundation awards Asceneuron a grant to treat Parkinson’s disease Committed to accelerating research into novel Parkinson’s Disease therapies, The Michael J. Fox Foundation for Parkinson’s Research is again awar...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Aktuell Oct 18, 2022 KetoSwiss erhöht Kapital um 4 Millionen Dollar KetoSwiss hat von Investoren 4 Millionen Dollar erhalten. Das Basler Start-up entwickelt Produkte zur Linderung neurologischer Erkankungen wie Mi...
News Sep 29, 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News Oct 19, 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News Oct 18, 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News Aug 24, 2023 Nanomedicine pioneer Nanobacterie achieves remarkable patent ranking Drawing from the achievements of its parent company, Nanobacterie, Valais-based AlphaOnco Swiss stands at the forefront of innovative nanomedicin...
News Aug 07, 2023 Longevity start-up EPITERNA raises EUR 10 million to slow ageing and extend lifespan Vaud-based longevity start-up EPITERNA has secured EUR 10 million in funding from Prima Materia, an investment firm founded by Spotify founder Da...
News Aug 14, 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Innovation Jul 11, 2023 Locate Investors Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your li...
News Mar 29, 2023 Western Switzerland’s sustainability innovators making global impact Western Switzerland is home to a range of sustainability start-ups that are making waves on the international stage.
Spotlight Jun 15, 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...